Sort
48,018 grants matching “immunotherapy”
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$452,151John H Sampson · Duke University · R01 · FY2012 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion
$452,097Chao Lu · Columbia University Health Sciences · R01 · FY2022 · DE
qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents
$452,096Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Dopamine, mutant synuclein, oxidative stress and inflammation
$452,081Howard J. Federoff · Georgetown University · R01 · FY2010 · NS
Genomics and Computational Biology Shared Resource
$452,002Kelly A Frazer · University Of California, San Diego · P30 · FY2021 · CA
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
$451,942Chen Yao · Ut Southwestern Medical Center · DP2 · FY2021 · AI
Improving anti-tumor immunity in advanced breast cancer by targeting solid stress
$451,940Dennis Jones · Boston University Medical Campus · R01 · FY2024 · CA
PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO HIV1
$451,939New York University School Of Medicine · R01 · FY2001 · HL
PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO HIV1
$451,939New York University School Of Medicine · R01 · FY2000 · HL
Developing newly combined therapeutic strategies for mature B cell lymphoma
$451,877Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Computer aided diagnosis of cancer metastases in the brain
$451,732Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2019 · LM
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$451,729Jonathan D Powell · Johns Hopkins University · U54 · FY2022 · CA
DEVELOPMENTAL FUNDS
$451,624William L. Carroll · New York University School Of Medicine · P30 · FY2014 · CA
STING-dependent activation of Natural Killer cells by viral and tumor DNA
$451,602David H Raulet · University Of California Berkeley · R01 · FY2021 · AI
Development of humanized transgenic mice for HBV/HIV co-infection studies
$451,591Larisa Y Poluektova · University Of Nebraska Medical Center · R21 · FY2019 · AI
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells
$451,561Fotini Gounari · University Of Chicago · R01 · FY2016 · AI
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$451,542Shivaani Kummar · Oregon Health & Science University · R01 · FY2021 · CA
Enhancing HSPC CAR-mediated immunity in vivo
$451,537Scott G Kitchen · University Of California Los Angeles · U19 · FY2023 · AI
Engineered Ensemble Nanoimmunotherapies for Cancer
$451,530Rohan Fernandes · George Washington University · R37 · FY2023 · CA
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$451,466David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$451,466David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
$451,422Evan Alexander Scott · Northwestern University · R01 · FY2021 · EB
Insonation of ultrasound microbubbles at low frequency to enhance image-guided therapy
$451,407Katherine W Ferrara · Stanford University · R01 · FY2021 · CA